Bioactivity | MAO A/HSP90-IN-1 (4-b) is a MAO A/HSP90 dual inhibitor with IC50 value of 1.77 μM and 0.019 μM in Glioblastoma (GBM) GL26 cells and HSP90α, respectively. MAO A/HSP90-IN-1 (4-b) can inhibit MAO A activity, HSP90 binding and the expression of HER2 and phospho-Akt to inhibit the growth of GBM, they also reduce PD-L1 expression, which inhibits T cell activation. MAO A/HSP90-IN-1 (4-b) have potential to inhibit tumor immune escape. MAO A/HSP90-IN-1 (4-b) can be used for brain tumor-related diseases research[1]. |
Invitro | MAO A/HSP90-IN-1 (4-b) (0.1 μM-3 μM, 24小时) 通过抑制 MAO A 和 HSP90,从而减少 GBM 细胞的增殖[1]。MAO A/HSP90-IN-1 (0.1 μM-3 μM, 24小时) 在 GL26 中的 IC50 为0.73 μM,在GL26中的 IC50 为1.68 μM,在 U251R 中的 IC50 为0.84 μM[1]。MAO A/HSP90-IN-1 (0μM, 0.35μM, 0.7μM, 1.4μM, 24小时) 在小鼠胶质瘤 GL26 细胞中抑制IFN-γ 诱导的PD-L1表达[1]。 0 --> MAO A/HSP90-IN-1 相关抗体: Cell Viability Assay[1] Cell Line: |
In Vivo | MAO A/HSP90-IN-1 (4-b) (25 mg/kg,腹腔注射,每天) 抑制 GBM 小鼠模型肿瘤生长[1]。 Animal Model: |
Name | MAO A/HSP90-IN-1 |
CAS | 2927489-95-8 |
Formula | C24H29ClN2O4 |
Molar Mass | 444.95 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Tseng HJ, et al. Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma. Eur J Med Chem. 2023 Aug 5;256:115459. |